HLHai-Dan Liu

Hai-Dan Liu

*This is an algorithmically generated author record based on publicly available information.

Hai-Dan Liu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Jun Qian

    Department of Thyroid Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P.R. China

    1 shared publication
  • Ming Zhang

    Department of Thyroid Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P.R. China

    1 shared publication
  • Quan Wang

    State Key Laboratory of Precision and Intelligent Chemistry, Department of Polymer Science and Engineering University of Science and Technology of China Hefei Anhui China

    1 shared publication
  • Ruochuan Cheng

    Department of Thyroid Surgery, Clinical Research Center for Thyroid Diseases of Yunnan Province, The First Affiliated Hospital of Kunming Medical University, Kunming, China

    1 shared publication
  • Shao-Hao Cheng

    Department of Thyroid Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P.R. China

    1 shared publication
  • Wen Liu

    Department of Thyroid Surgery, Clinical Research Center for Thyroid Diseases of Yunnan Province, The First Affiliated Hospital of Kunming Medical University, Kunming, China

    1 shared publication

Latest Publications

  • Open Access

    Neoadjuvant therapy with anlotinib in a locally advanced and pulmonary metastasis PTC patient harboring TERT promoter and BRAFV600E mutations: a case report

    by Yan-Jun Su, Shao-Hao Cheng, Jun Qian, Ming Zhang, Wen Liu, Xiang-Xiang Zhan, Zhu-Quan Wang, Hai-Dan Liu, Xing-Wei Zhong, Ruo-Chuan Cheng

    SUMMARY A 71-year-old woman with recurrent papillary thyroid carcinoma (PTC) was referred to our hospital. A computed tomography scan revealed extensive recurrence in the neck, invading sternocleidomastoid muscle, internal jugular vein, sternal end of the clavicle, strap muscle and skin; and lateral compartment and subclavian lymph nodes were also involved. Multiple pulmonary micrometastases also noticed. The tumor was considered unresectable; however, the patient was unwilling to accept highly invasive surgery. Therefore, we initiated neoadjuvant therapy with anlotinib, 12mg p.o. daily [...] SUMMARY A 71-year-old woman with recurrent papillary thyroid carcinoma (PTC) was referred to our hospital. A computed tomography scan revealed extensive recurrence in the neck, invading sternocleidomastoid muscle, internal jugular vein, sternal end of the clavicle, strap muscle and skin; and lateral compartment and subclavian lymph nodes were also involved. Multiple pulmonary micrometastases also noticed. The tumor was considered unresectable; however, the patient was unwilling to accept highly invasive surgery. Therefore, we initiated neoadjuvant therapy with anlotinib, 12mg p.o. daily